Literature DB >> 7518017

Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury.

S Suzuki1, L H Toledo-Pereyra.   

Abstract

The mechanisms by which polymorphonuclear neutrophils (PMNs) are recruited by the ischemic and reperfused liver are still unknown. The purpose of this study was to determine whether tumor necrosis factor-alpha (TNF) and/or interleukin-1 alpha (IL-1) acted as potential mediators for PMN infiltration after liver ischemia and reperfusion. The potential effect of FK 506, a powerful immunosuppressant, was also studied. Male Sprague-Dawley rats were subjected to 60 and 90 min of total hepatic ischemia, with an extracorporeal porto-systemic shunt. FK 506 (0.3 mg/kg) was intravenously administered 4 hr before ischemia (FK 506 group), and control animals received normal saline solution (NS group). Plasma TNF, IL-1 levels, and PMN infiltration in liver tissue were serially examined at the end of ischemia, 5, 30, 60, and 360 min after reperfusion. The degree of liver necrosis was assessed at 360 min following reperfusion. In the NS group, IL-1 and TNF revealed a transient elevation at 30 and 60 min after reperfusion, following 60 min of ischemia. When the ischemia was increased to 90 min, the IL-1 activity had a rapid elevation (330.5 +/- 129 pg/ml) at 5 min, which remained at high levels (197.8 +/- 70.4 pg/ml) until 6 hr after reperfusion, whereas the TNF activity decreased to normal levels following a similar peak (355 +/- 181.9 pg/ml) at 5 min after reperfusion. The time course of IL-1 release in the NS group, with 90 min of ischemia, correlated directly with the PMN infiltration.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518017     DOI: 10.1006/jsre.1994.1140

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  23 in total

1.  The protective effect of alpha-tocopherol and GdCl3 against hepatic ischemia/reperfusion injury.

Authors:  Dimitrios Giakoustidis; George Papageorgiou; Stavros Iliadis; Alexandros Giakoustidis; Evanthia Kostopoulou; Nickolas Kontos; Evropi Botsoglou; Dimitrios Tsantilas; Vasilios Papanikolaou; Dimitrios Takoudas
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

2.  Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells.

Authors:  Nozomu Sakai; Heather L Van Sweringen; Ritha M Belizaire; Ralph Cutler Quillin; Rebecca Schuster; John Blanchard; Justin M Burns; Amit D Tevar; Michael J Edwards; Alex B Lentsch
Journal:  J Gastroenterol Hepatol       Date:  2012-10       Impact factor: 4.029

Review 3.  Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury.

Authors:  Rosanna Di Paola; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-03-13       Impact factor: 3.000

4.  Specific role of interleukin-1 in hepatic neutrophil recruitment after ischemia/reperfusion.

Authors:  Atsushi Kato; Cem Gabay; Tomohisa Okaya; Alex B Lentsch
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

5.  Receptor activator of nuclear factor-κB ligand (RANKL) protects against hepatic ischemia/reperfusion injury in mice.

Authors:  Nozomu Sakai; Heather L Van Sweringen; Rebecca Schuster; John Blanchard; Justin M Burns; Amit D Tevar; Michael J Edwards; Alex B Lentsch
Journal:  Hepatology       Date:  2012-01-13       Impact factor: 17.425

6.  CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver.

Authors:  R M Zwacka; Y Zhang; J Halldorson; H Schlossberg; L Dudus; J F Engelhardt
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

7.  Effect of liver ischemia-reperfusion injury on the activity of neurons in the rat brain.

Authors:  Zdeno Pirnik; Jana Bundzikova; Tomas Francisty; Elena Cibulova; Lubica Lackovicova; Boris Mravec; Alexander Kiss
Journal:  Cell Mol Neurobiol       Date:  2009-03-13       Impact factor: 5.046

8.  Resveratrol attenuates oxidative stress and histological alterations induced by liver ischemia/reperfusion in rats.

Authors:  Ercan Gedik; Sadullah Girgin; Hayrettin Ozturk; Basra-Deniz Obay; Hulya Ozturk; Huseyin Buyukbayram
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

Review 9.  Role of ischemic preconditioning in liver surgery and hepatic transplantation.

Authors:  Eduardo E Montalvo-Jave; Enrique Piña; Cesar Montalvo-Arenas; Raúl Urrutia; Luis Benavente-Chenhalls; Julieta Peña-Sanchez; David A Geller
Journal:  J Gastrointest Surg       Date:  2009-04-30       Impact factor: 3.452

10.  Hepatocyte signaling through CXC chemokine receptor-2 is detrimental to liver recovery after ischemia/reperfusion in mice.

Authors:  Satoshi Kuboki; Thomas Shin; Nadine Huber; Thorsten Eismann; Elizabeth Galloway; Rebecca Schuster; John Blanchard; Michael J Edwards; Alex B Lentsch
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.